双重应用甲德酸改善了功能和解剖结果在糖尿病的拖拉性视网膜脱离
Ophthalmic surgery, lasers & imaging retina
|February 25, 2025
概括
双输送甲状腺素 (MTX) 与帕斯普拉纳视切除术 (PPV) 改善了糖尿病拖拉性视网膜脱落 (TRD) 患者的视觉敏度和视网膜功能. 这一战略为管理这种危及视力的疾病提供了一种有希望的方法.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜外科手术 视网膜外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病视网膜病变 (DR) 是导致失明的主要原因.
- 在糖尿病患者中,炎症显著导致拖拉性视网膜脱落 (TRD).
- 甲基 (MTX) 具有与TRD管理相关的抗炎性质.
研究的目的:
- 评估双交付甲状腺素 (MTX) 策略,用于糖尿病拖拉性视网膜脱落 (TRD).
- 为了评估MTX与帕斯普拉纳视切除术 (PPV) 结合的疗效,与单独的PPV相比.
主要方法:
- 一项试点研究涉及60名糖尿病TRD患者.
- 患者随机分配,接受MTX与PPV或单独PPV.
- MTX是通过手术期间灌和内注射进行的;结果评估是在油去除后一个月.
主要成果:
- 在MTX组中观察到视敏度 (VA) 和多焦点电网膜学 (mfERG) 的显著改善.
- 视网膜膜的减少,视网膜内层的失调和囊性黄斑变化在MTX组的SD-OCT上被注意到.
结论:
- 在PPV期间双交付MTX是糖尿病TRD的一个有希望的策略.
- 这种方法证明了提高功能和解剖结果的潜力.
- 进一步的研究可能会验证MTX作为糖尿病TRD的辅助疗法.
相关概念视频
Therapeutic Drug Monitoring: Affecting Factors
438
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438
Diabetic Retinopathy
65
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
65


